These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 26319013)

  • 1. Extrahepatic morbidity and mortality of chronic hepatitis C.
    Negro F; Forton D; Craxì A; Sulkowski MS; Feld JJ; Manns MP
    Gastroenterology; 2015 Nov; 149(6):1345-60. PubMed ID: 26319013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrahepatic manifestations of HCV.
    Grignoli R; Goossens N; Negro F
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):31-8. PubMed ID: 25390287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrahepatic manifestations in chronic hepatitis C virus carriers.
    Rosenthal E; Cacoub P
    Lupus; 2015 Apr; 24(4-5):469-82. PubMed ID: 25801890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifestations of chronic hepatitis C virus infection beyond the liver.
    Jacobson IM; Cacoub P; Dal Maso L; Harrison SA; Younossi ZM
    Clin Gastroenterol Hepatol; 2010 Dec; 8(12):1017-29. PubMed ID: 20870037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy: why does it fail in HCV-related chronic hepatitis?
    Masarone M; Persico M
    Expert Rev Anti Infect Ther; 2011 May; 9(5):535-43. PubMed ID: 21609265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
    Gragnani L; Piluso A; Urraro T; Fabbrizzi A; Fognani E; Petraccia L; Genovesi A; Giubilei L; Ranieri J; Stasi C; Monti M; Zignego AL
    Curr Drug Targets; 2017; 18(7):772-785. PubMed ID: 26853322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
    Rutledge SM; Chung RT; Sise ME
    Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
    Fan XH; Wang LF; Liu LC; Yao Y; Shan Y; Lu HY; Wu CH; Xu XY; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Extrahepatic Manifestations of Hepatitis C Virus.
    Degasperi E; Aghemo A; Colombo M
    Clin Liver Dis; 2017 Aug; 21(3):631-643. PubMed ID: 28689598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatologic manifestations of Hepatitis C Virus.
    Treppo E; Quartuccio L; Ragab G; DE Vita S
    Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
    Mazzaro C; Zorat F; Caizzi M; Donada C; Di Gennaro G; Maso LD; Carniello G; Virgolini L; Tirelli U; Pozzato G
    J Hepatol; 2005 May; 42(5):632-8. PubMed ID: 15826710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-related cryoglobulinemic vasculitis.
    Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
    Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
    Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD
    J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis.
    Cacoub P; Desbois AC; Comarmond C; Saadoun D
    Gut; 2018 Nov; 67(11):2025-2034. PubMed ID: 29703790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
    Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
    Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.
    Mahale P; Engels EA; Li R; Torres HA; Hwang LY; Brown EL; Kramer JR
    Gut; 2018 Mar; 67(3):553-561. PubMed ID: 28634198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.